Tags: acne | scars | dermal | filler | Bellafill

First Dermal Filler for Acne Scars OKd by FDA

Tuesday, 06 Jan 2015 12:28 PM


The U.S. Food and Drug Administration approved the first dermal filler to treat scarring caused by acne, the most common skin disorder in the United States afflicting 40-50 million people.
Bellafill, developed by privately held Suneva Medical Inc, has been developed to treat moderate to severe acne scars on the cheeks of patients over the age of 21.
A cure for acne has long eluded drug developers. And from topical gels to lasers, nothing so far has satisfactorily treated scarring that affects up to 95 percent of acne sufferers.
The U.S. Food and Drug Administration cleared a laser treatment for acne scarring in July, but adoption for this kind of therapy is limited by its high cost, associated pain, and the need for repeat treatments.

© 2017 Thomson/Reuters. All rights reserved.

 
1Like our page
2Share
Health-News
The U.S. Food and Drug Administration approved the first dermal filler to treat scarring caused by acne, the most common skin disorder in the United States afflicting 40-50 million people.Bellafill, developed by privately held Suneva Medical Inc, has been developed to treat...
acne, scars, dermal, filler, Bellafill
125
2015-28-06
Tuesday, 06 Jan 2015 12:28 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved